Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup study

D. S. Alberts, P. Y. Liu, E. V. Hannigan, R. O'Toole, S. D. Williams, J. A. Young, E. W. Franklin, D. L. Clarke-Pearson, V. K. Malviya, B. Dubeshter, W. J. Hoskins, M. D. Adelson, R. D. Alvarez, J. O'Sullivan, D. J. Garcia, D. B. Sparks, J. Quade, M. L. Rothenberg

Research output: Contribution to journalArticle

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)28-29
Number of pages2
JournalInternational Journal of Gynecological Cancer
Volume6
Issue number5 SUPPL. 1
StatePublished - Aug 27 1996

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Alberts, D. S., Liu, P. Y., Hannigan, E. V., O'Toole, R., Williams, S. D., Young, J. A., Franklin, E. W., Clarke-Pearson, D. L., Malviya, V. K., Dubeshter, B., Hoskins, W. J., Adelson, M. D., Alvarez, R. D., O'Sullivan, J., Garcia, D. J., Sparks, D. B., Quade, J., & Rothenberg, M. L. (1996). Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup study. International Journal of Gynecological Cancer, 6(5 SUPPL. 1), 28-29.